Restore RFRA waiver for importing vaccines free of aborted-fetal cell lines
Mandate says FDA should restore the January 2021 OCR–FDA waiver allowing bulk importation of certain Japanese vaccines to accommodate religious needs, revoked by Biden FDA, and require future biologics free of moral taint.
Mandate
Mandate Ch. 14 (HHS) — FDA Vaccine Importation: restore the RFRA-based waiver for bulk importation by doctors of certain Japanese-made vaccines; FDA and NIH should require development of drugs/biologics free from aborted fetal cell lines.
Undo plan
1) Maintain science-based biologics standards without categorical bans on historically used cell lines that underpin many licensed vaccines.
2) Create transparent religious-accommodation pathways for clinically equivalent alternatives where available, with safety review.
3) Fund research into alternative manufacturing substrates without destabilizing childhood immunization schedules.
4) Publish OCR–FDA joint guidance on RFRA accommodation scope.
5) Verify: vaccination coverage rates; documented accommodation processing times.